Loading...
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft-tissue sarcomas. The excised tissue of a single patient in the microdose administration group was imaged with both a wi...
Na minha lista:
| Udgivet i: | Proc SPIE Int Soc Opt Eng |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783124/ https://ncbi.nlm.nih.gov/pubmed/31595101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1117/12.2510935 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|